Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) 3-Year Book Growth Rate : -6.20% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Luoxin Pharmaceuticals Group Stock Co 3-Year Book Growth Rate?

Luoxin Pharmaceuticals Group Stock Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥2.15.

During the past 12 months, Luoxin Pharmaceuticals Group Stock Co's average Book Value per Share Growth Rate was -24.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was -6.20% per year. During the past 5 years, the average Book Value per Share Growth Rate was -25.80% per year. During the past 10 years, the average Book Value per Share Growth Rate was 11.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Luoxin Pharmaceuticals Group Stock Co was 87.60% per year. The lowest was -34.20% per year. And the median was 16.60% per year.

Competitive Comparison of Luoxin Pharmaceuticals Group Stock Co's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Luoxin Pharmaceuticals Group Stock Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Luoxin Pharmaceuticals Group Stock Co's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Luoxin Pharmaceuticals Group Stock Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Luoxin Pharmaceuticals Group Stock Co's 3-Year Book Growth Rate falls into.

Luoxin Pharmaceuticals Group Stock Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Luoxin Pharmaceuticals Group Stock Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Luoxin Pharmaceuticals Group Stock Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

N/A

Address

85 Faraday Road, Floor 1-3, Building 1, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

http://www.luoxin.cn

Luoxin Pharmaceuticals Group Stock Co Ltd is a pharmaceutical enterprise engaged in research and development, production, and trade of new drugs. It manufactures drugs for various diseases including tumor, respiratory, gastrointestinal, endocrine, cardiovascular, nervous system, antimicrobial infection, among others.

Executives

Ye Bang Mi	Supervisors
Fang Xiu Bao	Directors, executives
Zhu Fu Lin	Directors, executives
Chen Li	Supervisors
Yao Liang	Directors, executives

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Headlines

No Headlines